Odysight.ai (NASDAQ: ODYS) Launches First US Flight Test of AI Maintenance System

March 6, 2026

Key Developments Odysight.ai (NASDAQ: ODYS) has unveiled a new partnership with XP Services to conduct the inaugural U.S.-based flight testing of its advanced AI-driven predictive maintenance system. This milestone installation is scheduled to take place on a UH-60 helicopter this spring, marking the company’s first deployment of its technology on an aircraft within the United States. This development represents a major progression in Odysight.ai’s U.S. expansion initiatives, positioning the company…

Read More >>

Off The Hook YS Inc. (NYSE American: OTH) Announces Upcoming Investor Webinar and Q&A Session

March 6, 2026

Expert Analysis Off The Hook YS Inc. (NYSE American: OTH) is positioned uniquely as the biggest buyer and seller of used boats in the United States, creating significant opportunities in the marine marketplace sector. As a vertically integrated platform powered by artificial intelligence, Off The Hook YS Inc. continues to leverage technology to optimize the buying and selling experience for boating enthusiasts and investors alike. Engagement initiatives such as live…

Read More >>

Averin Capital Acquisition Corp. (NASDAQ: ACAAU) Reports Partial Exercise of IPO Over-Allotment Option

March 5, 2026

Market Overview The initial public offering (IPO) market continues to show robust activity, with Averin Capital Acquisition Corp. (NASDAQ: ACAAU) making notable progress in its capitalization efforts. The company has experienced positive reception from investors, reflected in the recent partial exercise of the IPO over-allotment option underwritten for the offering. This development indicates strong demand and confidence in Averin Capital Acquisition Corp. as it establishes its market presence. Following the…

Read More >>

Research Frontiers Inc. (NASDAQ: REFR) Announces Q4 and Full Year 2025 Financial Results

March 5, 2026

Expert Analysis Research Frontiers Inc. (NASDAQ: REFR) delivering its fourth quarter and full year 2025 financial results offers a critical window into the company’s operational health and future prospects. Analysts and investors are likely to scrutinize these figures to better understand the company’s trajectory amid evolving market conditions and technological advancements in their sector. Given Research Frontiers Inc.’s position within the innovative materials market, the latest financial disclosures could shed…

Read More >>

Coda Octopus Group (NASDAQ: CODA) Announces Fiscal Q1 2026 Earnings Call Schedule

March 5, 2026

Market Overview The market is eagerly anticipating the upcoming financial performance disclosure from Coda Octopus Group (NASDAQ: CODA), a renowned leader in advanced imaging sonar and subsea intelligence technologies. Investors and analysts are focused on the company’s fiscal first quarter results for 2026, which are expected to provide insights into the ongoing demand for its innovative underwater imaging solutions. Shares of Coda Octopus Group have drawn attention recently as the…

Read More >>

Fitell Corporation (NASDAQ: FTEL) Completes Redomiciliation to British Virgin Islands

March 5, 2026

Expert Analysis Fitell Corporation’s (NASDAQ: FTEL) move to redomicile from the Cayman Islands to the British Virgin Islands represents a strategic corporate restructuring aimed at optimizing legal and operational frameworks. This transition aligns with the company’s broader objectives to strengthen its governance and potentially enhance shareholder value by operating under BVI regulations. The decision, approved by shareholders, indicates strong internal support for navigating international corporate environments that offer favorable business…

Read More >>

TAP Real Estate Technologies (OTC: RWAX) Completes Name Change and Ticker Update

March 4, 2026

Expert Analysis The completion of the corporate name change and ticker update marks a significant strategic pivot for TAP Real Estate Technologies, Inc. (OTC: RWAX). This repositioning underscores the company’s commitment to redefining real estate asset management through enhanced digital infrastructure solutions. By realigning its brand identity, TAP Real Estate Technologies is poised to capture new growth opportunities in the efficient issuance and trading of real-world assets. Such a transformation…

Read More >>

Ellomay Capital Ltd. (NYSE American: ELLO) Updates on Shareholder and Board Changes

March 4, 2026

Market Overview Ellomay Capital Ltd. (NYSE American: ELLO), a key player in renewable energy and power development across Europe, Israel, and the USA, is a company of growing interest in the NYSE American market. Over recent periods, energy and renewable sectors have attracted considerable attention due to increasing global commitments toward clean energy. As such, ELLO stock has experienced dynamic shifts influenced by company developments, investor actions, and market trends….

Read More >>

SCWorx Corp. (NASDAQ: SCWX) Secures New SaaS Deal with Southeastern Healthcare Provider

March 4, 2026

Expert Analysis SCWorx Corp. (NASDAQ: SCWX) continues to strengthen its position in the healthcare data management sector by partnering with large-scale healthcare providers integrating advanced technology platforms. The agreement with a major Southeastern healthcare system highlights the growing demand for sophisticated SaaS data solutions that streamline the complex workflows of delivery networks and enhance operational efficiency. This new customer engagement underscores SCWorx Corp.’s expertise in supporting Workday platform implementations, showcasing…

Read More >>

Autonomix Medical (NASDAQ: AMIX) Highlights Novel Nerve Treatment at CRT 2026

March 4, 2026

Market Overview Autonomix Medical, Inc. (NASDAQ: AMIX) is gaining attention as it prepares for a high-profile presentation at the upcoming Cardiovascular Research Technologies (CRT) 2026 Meeting in Washington, DC. This event draws significant interest from investors and professionals in the medical technology sector, spotlighting companies advancing innovative treatments. AMIX stock observers are watching closely as the company shares new clinical data showcasing its impact on nerve-targeted therapies. The broader market…

Read More >>